Realbotix Reports Financial Results for Q2-2026
Go back to Realbotix Reports Financial Results for Q2-2026| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.68 +0.03 (4.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $0.00 | |||
| Open | $0.64 | 52 Week Low | $0.00 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $0.00 | |||
| Volume | 164,317 | |||||
| (AMEX: XBOTF) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $ | |||
| Open | $0.19 | 52 Week Low | $ | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $ | |||
| Volume | 192,078 | |||||
